Does low testosterone actually worsen ADHD symptoms in women?

What did @drjolenebrighten actually say?

Dr. Brighten argues that low testosterone in women drives ADHD-like symptoms, specifically "trouble getting started" and following through on tasks. She frames the FDA's narrow approval of testosterone therapy for low libido in women as shortsighted, suggesting testosterone's role in mood, cognition, and executive function is being ignored by regulators. Her closing line, "give women the hormones they need," positions testosterone as an underrecognized solution for women struggling with ADHD symptoms.

She stops short of telling viewers to go get testosterone, which is worth noting. The framing is more "ask questions" than "here's your prescription." But the implied direction is clear: if your laundry pile is spiraling, your hormones might be the reason, not your habits.

Does the science back this up?

Partially, and with important caveats. There is legitimate research connecting androgens, including testosterone, to dopaminergic function, which is the same neurotransmitter system implicated in ADHD. This is not fringe science. But the evidence that low testosterone specifically causes or worsens ADHD in women is thin.

A 2020 review by Bäckström et al. in Frontiers in Neuroendocrinology confirmed that sex hormones modulate dopamine and norepinephrine signaling, both central to attention regulation. And Nadeau's work on women with ADHD (2002, published in the Journal of Clinical Psychology) raised early flags that hormonal fluctuations across the menstrual cycle and perimenopause affect ADHD symptom severity. More recently, a 2023 study by Zetterqvist et al. in BMJ Mental Health found elevated rates of ADHD diagnoses around perimenopause, suggesting a hormonal connection that deserves more clinical attention.

The problem is that "hormones affect brain chemistry" and "testosterone supplementation reliably reduces ADHD symptoms" are two very different claims. We have strong evidence for the first. We do not have well-powered randomized controlled trials proving the second in women.

What did they get wrong (or right)?

She gets credit for correctly identifying that ADHD in women is under-researched and that hormonal transitions matter. That's fair, and the science supports her directionally. The Zetterqvist data on perimenopause and ADHD is real.

Where she oversimplifies: calling unfinished laundry a potential testosterone problem is a rhetorically satisfying leap that skips over a dozen other plausible explanations, including sleep deprivation, thyroid dysfunction, depression, or, you know, actually having ADHD that was never treated. The video doesn't draw a clear line between correlation and causation. Testosterone is low and symptoms are present does not mean testosterone caused the symptoms.

Her FDA criticism is partially valid. The agency has not approved any testosterone product specifically for women in the U.S., and the evidentiary standards applied to female sexual interest disorder have been criticized by endocrinologists as inconsistently applied compared to male hypogonadism research (Davis et al., 2019, The Lancet Diabetes and Endocrinology). But the FDA's caution also reflects genuine gaps in long-term safety data for testosterone in women, which she doesn't mention.

What should you actually know?

If you're a woman with ADHD whose symptoms are getting harder to manage in your 40s, hormonal changes are a legitimate variable worth discussing with a clinician. That's the reasonable takeaway here. Estrogen and testosterone both influence the dopamine system, and perimenopause disrupts both. This is not pseudoscience.

What it doesn't mean is that testosterone therapy is a treatment for ADHD, or that checking a testosterone level should replace a proper ADHD evaluation. The American College of Obstetricians and Gynecologists does not currently recommend testosterone for cognitive symptoms or ADHD, and off-label use carries real considerations including cardiovascular effects, polycythemia risk, and virilization at higher doses.

If you're considering hormone evaluation, that conversation belongs with a clinician who can look at your full picture, not a 60-second video. Symptoms like fatigue, poor concentration, and brain fog have a long differential diagnosis list. Testosterone is one variable on it. It's not the answer key.